[1] Starrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells[J].Biochemistry(Mosc), 2000, 65 (1) :95?106.

[2] 陈慧玲. 肿瘤多药耐药的研究进展[J].临床肿瘤学杂志, 2008,13(5):475?477.

[3] Scheffer GL, Wijingard PL, Flens MJ,et al.The drug resistance related protein LRP is the human major vault protein[J]. Nat Med, 1995,1(6):578?582.

[4] Zquierdo MA, Scheffer GL, Flens MJ,et al.Broad distribution of the multidrug resistance?related vault lung resistance protein in normal human tissues and tumors[J].Am J Pathol,1996,148(3):877? 887.

[5] Dingemans AM,Witlox MA,Stallaert RA,et al.Expression of DNA topoisomerase II alpha and topoisomerase Iibeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res,1999,5 (8):2048?2058.

[6] 郑少江,吴焕明,王伟.LRP、TopoⅡ在非小细胞癌肺癌中的协同表达及其临床意义[J].中国组织化学与细胞化学杂志,2004, 13(2): 180?183.

[7] 张燕，金先庆， 赵珍珍，等.5种耐药基因在成人常见恶性肿瘤中的表达特点[J].重庆医科大学学报，2007,32(10)：1023?1027.

[8] Ranganathan S , Tew KD.Immunohistochemical localization of glutathione S?transferases alpha ,mu ,and pi in normal tissue and carcinomad from human colon[J].Carcinogenesis, 1991, 12:2383.

[9] Volm M, Matten J.Expresson of several resistant mechanisms in untreated human kidney and lung carcinomas[J]. Anticancer Research, 1992,12:1063?1068.

[10] 陆芹,吴德明, 管惟苓.P?gp、TopoⅡ和GST?π在大肠癌中的表达及其意义[J].江苏医药杂志,2002, 28(1)：8?11.

精品学习网 医药卫生栏目